Piperidine compound and process for preparing the same.

Details for Australian Patent Application No. 2004293306 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Asai, Hidetoshi; Miyake, Tsutomu; Takahashi, Masami; Kono, Rikako; Yamanaka, Takeshi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004293306

PCT Pub. Number WO2005/051912

Priority 2003-398368 28.11.03 JP

Filing date 26 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 25 September 2008

International Classifications

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

C07D 211/38 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/54 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/56 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/02 Drugs for immunological or allergic disorders

Event Publications

20 July 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Piperidine compound and process for preparing the same. 2004293717 LG Electronics Inc. The nature of the amendment is as shown in the statement(s) filed 15 Jun 2006

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/051912 Priority application(s): WO2005/051912

25 September 2008 Alteration of Name

  The name of the applicant has been altered to Mitsubishi Tanabe Pharma Corporation

25 September 2008 Application Accepted

  Published as AU-B-2004293306

22 January 2009 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293310-Quinazoline derivative and process for producing the same

2004293289-Synthetic resin heat-resistant bottle type container